Clinical trials
5 active studies led by Disc Medicine, Inc, of 11 in all
Source: ClinicalTrials.gov, Studies with Disc Medicine, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Disc Medicine, Inc in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Disc Medicine, Inc or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Source: SEC EDGAR, Company filings, CIK 1816736. Retrieved 13 Nov 2026.
5 active studies led by Disc Medicine, Inc, of 11 in all
Source: ClinicalTrials.gov, Studies with Disc Medicine, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1816736.
Studies Disc Medicine, Inc leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Disc Medicine, Inc or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Disc Medicine, Inc: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Disc Medicine, Inc is in.
Stories on the topics Disc Medicine, Inc works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Read